These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31880252)
1. Design, Synthesis, and Biological Evaluation of 4-amino Substituted 2Hchromen- 2-one Derivatives as an NEDD8 Activating Enzyme Inhibitor in Pancreatic Cancer Cells. Zhu L; Lu P; Gong L; Lu C; Li M; Wang Y Med Chem; 2020; 16(7):969-983. PubMed ID: 31880252 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Biological Evaluation of Coumarin Derivatives as NEDD8 Activating Enzyme Inhibitors in Pancreatic Cancer Cells. Gong L; Lu P; Lu C; Li M; Wan H; Wang Y Med Chem; 2022; 18(6):679-693. PubMed ID: 34895126 [TBL] [Abstract][Full Text] [Related]
3. A novel NAE/UAE dual inhibitor LP0040 blocks neddylation and ubiquitination leading to growth inhibition and apoptosis of cancer cells. Lu P; Guo Y; Zhu L; Xia Y; Zhong Y; Wang Y Eur J Med Chem; 2018 Jun; 154():294-304. PubMed ID: 29843100 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of isoprenylated coumarins as potential anti-pancreatic cancer agents. Jun M; Bacay AF; Moyer J; Webb A; Carrico-Moniz D Bioorg Med Chem Lett; 2014 Oct; 24(19):4654-4658. PubMed ID: 25205194 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. Paul K; Bindal S; Luxami V Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents. Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents. Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D. Zheng L; Gao T; Ge Z; Ma Z; Xu J; Ding W; Shen L Eur J Med Chem; 2021 Mar; 214():113226. PubMed ID: 33582387 [TBL] [Abstract][Full Text] [Related]
11. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation. Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218 [TBL] [Abstract][Full Text] [Related]
12. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells. Yan YY; Shi KY; Teng F; Chen J; Che JX; Dong XW; Lin NM; Zhang B Acta Pharmacol Sin; 2020 Jun; 41(6):835-842. PubMed ID: 32047260 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells. Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents. Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819 [TBL] [Abstract][Full Text] [Related]
15. Structure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposing. Wu KJ; Zhong HJ; Li G; Liu C; Wang HD; Ma DL; Leung CH Eur J Med Chem; 2018 Jan; 143():1021-1027. PubMed ID: 29232579 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of synthetic coumarins for antiausterity cytotoxicity against pancreatic cancers. Farley CM; Dibwe DF; Ueda JY; Hall EA; Awale S; Magolan J Bioorg Med Chem Lett; 2016 Mar; 26(5):1471-4. PubMed ID: 26832787 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative. Devji T; Reddy C; Woo C; Awale S; Kadota S; Carrico-Moniz D Bioorg Med Chem Lett; 2011 Oct; 21(19):5770-3. PubMed ID: 21880488 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway. Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents. Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]